Currently available Parkinson’s disease treatments, while capable of improving the early symptoms of the disease, lose their effect as the disease progresses and produce involuntary writing movements in the patients. As of yet there is no cure for the disease, which is the second most common neurodegenerative disease and affects over 7 million people worldwide. International Stem Cell Corp. (OTC: ISCO), a leader in using pluripotent stem cells in regenerative medicine, this morning issued news regarding its stem cell technology – signaling a potential blockbuster shift it the treatment of Parkinson’s disease.

ISCO today announces that its wholly owned subsidiary, Cyto Therapeutics, has received regulatory approval by the Therapeutics Goods Administration (TGA) of Australia to initiate a phase I/IIa clinical trial, dose escalation trial of human parthenogenetic stem cells-derived neural stem cells (ISC-hpNSC) in patients with moderate to severe Parkinson’s disease.

“We are very pleased to start the first human study of ISC-hpNSC’s for the treatment of this debilitating disease. There is a large unmet medical need for new treatments that may halt or reverse the progression of Parkinson’s disease and we believe our human neural stem cells may fill this need for the millions of people with this disease” stated Andrey Semechkin, PhD, ISCO’s chief executive officer. “We look forward to reporting on the progress of the clinical trial over the coming months.”

ISCO last year announced positive results from its preclinical studies for its ISC-hpNSC therapeutic candidate. In those preclinical studies, the cells demonstrated an improvement in Parkinson’s disease symptoms and increase in brain dopamine levels following the intracranial administration of ISC-hpNSC. The studies further noted that the ISC-hpNSCs provided neurotrophic support and cell replacement to dying dopaminergic neurons.

About the clinical study

The upcoming phase I/IIa clinical study – which will be performed at Royal Melbourne Hospital in Melbourne, Australia – is a dose escalation safety and preliminary efficacy study of human parthenogenetic stem cells-derived neural stem cells (ISC-hpNSC) intracranially transplanted into patients with moderate to severe Parkinson’s disease. The open-label, single center, uncontrolled clinical trial will evaluate three different dose regimens of 30 million-70 million neural cells. A total of 12 participants with moderate to severe Parkinson’s disease will be treated. Following transplantation, the patients will be monitored for 12 months at specified intervals, to evaluate the safety and biologic activity of ISC-hpNSC.

“We are the first company in the world to conduct clinical trials of human pluripotent stem cells based product for the treatment of Parkinson’s disease. We believe the outcome of the study will produce findings in-line with our preclinical studies, where we demonstrated not only safety of our proprietary neural stem cells, but also their functional efficacy. The cells were able to successfully integrate into the brain and provide a significant increase of dopamine levels in the nigrostriatal system” commented Russell Kern, PhD, ISCO’s executive vice president and chief scientific officer.

For more information, visit www.internationalstemcell.com

Let us hear your thoughts: International Stem Cell Corp. Message Board

It’s the most wonderful time of the year and what better way to celebrate the holidays than with a Christmas party at Giggles N’ Hugs (OTC: GIGL) for a little healthy holiday cheer. Santa also recently stopped by in his sleigh to meet with the excited little youngsters, answer wish lists and find out who’s been naughty or nice.

Giggles N’ Hugs adds a much needed healthy, organic and local twist to all its menu items, so, while your kids are enjoying a little playtime, you can munch on some edamame and mahi mahi with a glass of Pinot Grigio to settle your nerves. The Christmas season is meant to be a joyous and happy time spent with family and friends, but everyone likes a deal. That’s why every Tuesday, Giggles N’ Hugs offers its ‘Two for Tuesdays’ promotion – you buy one adult meal and admission for one child, a second child gets in free.

George Bernard Shaw said it best when he stated, “We don’t stop playing because we grow old. We grow old because we stop playing.” Letting go and not taking yourself so seriously all the time is a healthy habit everyone should incorporate into their lives, but doing so in a home or office setting isn’t realistic. Playing with your kids at one of the Giggles N’ Hugs locations could be just what the doctor ordered.

Membership has its privileges, and the company offers several options to save you time and money. Choose from a one, three or six month unlimited play pass for one to three children for a big discount. Also, you can conveniently make these purchases online through the company’s website.

Giggles N’ Hugs has been voted Los Angeles’s #1 Kids Party Place, #1 Family Restaurant, and #1 Indoor Playspace. It has three locations serving the greater Los Angeles area and offers magic shows, puppet shows, DJ’s, face painting, scavenger hunts, dance parties, karaoke and so much more. Come join the fun, and enjoy a healthy snack while your kids have the time of their lives.

For more information, please visit www.gigglesnhugs.com

Let us hear your thoughts: Giggles ‘N Hugs, Inc. Message Board

In November 2015, Agora Holdings, Inc. (OTC: AGHI), through wholly-owned subsidiary Geegle, completed development of TECH, a workflow management application for small- to medium-sized companies (SMEs). TECH simplifies task assignment and was developed to solve some of the logistical problems experienced by companies in the cable and telecommunications industry. Agora’s CEO, Danail Terziev, who holds a master’s in telecommunications, acquired direct knowledge of these problems when he worked at Comcast (NASDAQ: CMCSA) and Rogers Communications (NYSE: RCI). With TECH, telecom technicians can receive, accept, assign, and re-assign work orders received from customers.

TECH is a software nerve center. With it, technicians are always in touch with the office and the office knows the exact status of every job, whether it’s a technician visiting a customer or doing paperwork for that customer. Tasks can be assigned and tracked at anytime from anywhere. TECH pulls together scattered team efforts. It increases team visibility, team productivity and worker accountability by showing who’s working on what, what’s being worked on, and how much time it took. Putting work orders through this internal system improves planning, organization and efficiency as it pins down worker availability, strategically re-assigns work load, and tracks task progress.

TECH helps the technician to be more productive, and it’s a boon to his employer as well. TECH generates data that provides valuable insight into employee performance and customer needs. Future versions of TECH will allow for team chat that can be used to gather feedback from supervisors and team members in real time. Client companies are able to use the software by licensing it for $100 per month. They may also open the software in test mode for a smaller monthly fee to begin creating and executing tasks. To date, interest has been garnered from three cable companies to license the application. Contracts have been sent out and Geegle Operations are awaiting their go-ahead.

Agora Holdings, Inc., together with subsidiary Geegle Media and affiliates, is a leading diversified international family entertainment and media enterprise with five business segments: media networks, TV, studio entertainment, consumer products and interactive media. Agora brings together the best in media and technology. The company is driven by the mission to create the world’s best entertainment and online experiences. It’s dedicated to creating bespoke web products that fulfill the public’s insatiable appetite for social media platforms and apps, TV on Demand, and data storage applications. Operating under the domain name, www.geegle.tv, Geegle Media has, so far, developed a Video on Demand platform which services Canada, the United States, Russia and Bulgaria. Agora’s TECH software is a makeover for the cable guy. No need to be worried about him now.

For more information, visit the company’s website at www.geeglemedia.ca.

In 2014, the largest Ebola epidemic in history struck countries in West Africa, catching the attention of media outlets around the world and reaffirming the destructive power that viruses can have on unprepared civilizations. Viruses come in many shapes and sizes. From relatively inert bugs such as the common cold to dangerous, life-threatening infections like human immunodeficiency virus (HIV), influenza and dengue fever, viruses are found in almost every ecosystem on Earth, making them the most abundant type of biological entity on the planet.

Unlike bacteria, which are mostly harmless and often aid in the function of the human body, viruses are almost always bad news. These tiny organisms attach themselves to healthy cells within the body and, in many cases, reprogram those cells to create new viruses until the cells eventually burst and die. In other cases, viruses transform normal, healthy cells into malignant or cancerous cells. Although viruses are small (the largest virus is still smaller than even the smallest of bacteria), they are vicious. Most viruses target specific cells within the body, such as those in the liver, respiratory system or blood, causing serious, long-term health risks for infected individuals.

Because viruses hijack native cells and reprogram them in order to spread, effectively targeting a virus without harming its host organism’s cells is particularly difficult. When combined with viruses’ ability to mutate in order to counter attempts to inhibit their development, creating a universally effective antiviral medication becomes nearly impossible. Instead, pharmaceutical companies dodge mutations by taking preemptive measures. By administering small, relatively safe doses of viruses to patients, patients’ immune systems can be educated regarding particular viral infections, making future infections much less likely. These doses are known as vaccines.

Vaccines, much like viruses, come in a variety of shapes and sizes, and the world’s largest pharmaceutical companies are continuing to develop and innovative this preemptive treatment option in an effort to keep up with major viral threats. Vaccines are often extremely effective. Measles, for example, is one of the leading causes of death among young children, according to the World Health Organization, but a single dose of the MMR (measles, mumps and rubella) vaccine, which was developed in 1971 by Merck (NYSE: MRK), is 93 percent effective at preventing the deadly virus, according to the Centers for Disease Control and Prevention.

Not all vaccines are as consistently effective as the MMR vaccine, however. Influenza vaccines, such as those regularly developed by Sanofi (NYSE: SNY) and GlaxoSmithKline (NYSE: GSK), demonstrate the limitations of preemptive virus treatment. Because the influenza virus mutates very rapidly, flu shots are developed twice each year, but outbreaks of mutated strains still occur from time to time. To illustrate this, consider the 2009 flu pandemic, which involved the deadly H1N1 influenza virus, commonly known as swine flu. After patients are infected with an unforeseen virus mutation, vaccines are rendered totally ineffective, leaving biopharmaceutical companies to turn to alternative approaches to address these dangerous illnesses.

NanoViricides, Inc. (NYSE MKT: NNVC) is a nano-biopharmaceutical company that’s attempting to usher in a whole new era in medicine. The company’s innovative nanoviricide® antiviral therapeutics are nanomachines that are armed to destroy a particular type of virus. By programming information about a specific virus into the nanoviricide – similar to the postal address on an envelope – the company’s treatment fools a virus that’s already in a person into attaching to it. Shortly after attachment, the nanoviricide encapsulates the virus particle and absorbs its coat proteins. Without those proteins, the virus is unable to bind to a cell, rendering it neutralized and effectively destroyed.

Utilizing its versatile platform technology, NanoViricides is currently developing drugs against a number of viral diseases – including H5N1 bird flu, seasonal influenza, HIV, epidemic keratoconjunctivitis (EKC), hepatitis C, rabies, dengue fever and Ebola virus, among others. The company’s broad-spectrum nanoviricides, which it’s developing to combat several neglected tropical diseases, can bind to as many as 95 percent of known viruses, according to company data. NanoViricides’s most advanced product candidate, injectable FluCide™, is currently being studied in IND-enabling trials for the treatment of severe influenza with hospitalization.

In a quarterly report filed earlier this year, NanoViricides outlined its considerable progress in recent months. In particular, the company highlighted the advancement of its HerpeCide™ program, which it expects to contribute to the ongoing development of topical drugs to control herpes virus outbreaks for a number of indications – including oral lesions and shingles. Assuming positive results from its animal studies, NanoViricides expects these programs to result in extremely effective drugs.

According to its latest financial report, NanoViricides estimates that it has enough cash on hand to perform initial human clinical trials on at least one of its promising drug candidates, as well as advancing at least one additional candidate toward initial clinical trials. With HerpeCide and injectable FluCide currently leading the way, the company is in a favorable strategic position to put its promising therapeutic candidates to the test in the coming months, ahead of potential commercialization. For prospective shareholders, NanoViricides, complete with its innovative approach to targeted antiviral therapeutics, represents an extremely intriguing investment opportunity in the rapidly evolving biopharmaceutical industry.

For more information, visit www.nanoviricides.com

Transitioning to a healthy lifestyle is essential for developing a better quality of life and extending your lifespan. With so many cheap, quick and easy, fast food chains on every corner of America, sometimes that seems like a monumental task, but, in today’s world of smartphone technology and ‘app-hungry’ consumers, Content Checked Holdings, Inc. (OTC: CNCK) is aiding the health conscience shopper with its easy-to-use ContentChecked and SugarChecked apps.

The company’s apps were recently featured in the DIY Active article “Healthy Kitchen Tips: 4 Easy Steps” by clinical nutritionist Tara Zamani where she outlines a guide to healthy living using readily available tips, products, and technology. Zamani emphasizes the importance of getting into the habit of cooking and making it a priority in your life. Once you do this for a while, it becomes fun and is unlike any other activity because of the joys associated with feeling healthier from your own making and, of course, helping your family do the same.

Before jumping into the kitchen, you need the proper ingredients for a healthy concoction. Here is where she illustrates the significance of savvy shopping via ContentChecked’s family of innovative mobile apps. With the SugarChecked app, once you scan a food item, an alert is issued based on personal dietary sugar/sweetener preferences, and then the app provides you with a list of satisfactory alternatives. The ContentChecked app works very similarly, except that it alerts the user based on personal allergy settings and then offers a list of acceptable replacements.

The company’s goal is to continue building an environment that will foster healthier and happier lives through personally targeted information. The key to a healthier way of life is in the palm of your hand thanks to Content Checked Holdings. All you need to do is download the apps and start shopping.

For more information, visit the company’s website at www.ContentChecked.com.

In October, Dominovas Energy Corporation (OTC: DNRG) announced a landmark capital commitment of $1.2 billion in project financing to support the manufacture and deployment of its proprietary RUBICON™ solid oxide fuel cell (SOFC) system. This unprecedented commitment is expected to play a pivotal role in the company’s ongoing efforts to fulfill over 200MWs of signed and guaranteed power purchase agreements (PPAs) in the Democratic Republic of the Congo and allow for continued acquisition of additional PPAs throughout sub-Saharan Africa.

At the heart of DNRG’s recent performance is its cutting-edge multi-megawatt RUBICON™ SOFC system. The RUBICON™ is a fuel-flexible, highly efficient, and scalable approach to power generation. Taking into account that fuel sources vary from country to country, the RUBICON™ is able to incorporate a number of different fuels into its operation. In fact, DNRG states that the RUBICON™ will reform almost any hydrocarbon fuel into a suitable syngas composition, allowing for optimal stack electricity generation. Also, by implementing a thermal conversion process, DNRG’s technology is able to achieve a significant efficiency gain of roughly 60 percent over any combustion-based electricity production process.

In addition to improved efficiency, the RUBICON™ provides the means for additional value propositions through the flexibility of cogeneration. When generating power, the SOFC system produces useful heat and emits water, which can be further utilized for heating and cooling, providing an opportunity to improve overall system efficiency to more than 85 percent. When combined with the option to place power generation in the immediate proximity to the end-user in order to eliminate the high costs of infrastructure and transmission line maintenance, the RUBICON™ offers frontier markets around the globe an opportunity to greatly improve their power generation capacity in an affordable, efficient and environmentally-responsible manner.

For prospective shareholders, DNRG represents an opportunity to invest in the ongoing infrastructure development of countries in sub-Saharan Africa and around the world. According to a report by McKinsey & Company, sub-Saharan Africa currently includes seven countries with electrification of 50 percent or less, but that statistic is set to change. By 2040, the report estimates that demand for electricity will increase fourfold and more than 70 percent of the population will have access to reliable power. As DNRG prepares to fulfill its first PPA in the region in the coming months, this demand should place the company in a strong strategic position to promote sustainable financial growth.

For more information, visit www.dominovasenergy.com

Let us hear your thoughts: Dominovas Energy Corp. Message Boards

Moxian, Inc. (OTC: MOXC), a leader in online-to-offline marketing platforms, offers social marketing and promotion platforms to merchants who wish to promote their businesses through online social media. For five years, Moxian has delivered its platform to e-commerce operators, manufacturers, news media, payment providers, retail merchants, shopping mall operators, software developers and telecommunication and transportation providers from its base in Shenzhen, China.

Moxian’s products and services empower interactions between its merchant clients and its consumer users. The company designs its products and services to allow merchant clients to run advertising campaigns and promotions targeting customers. Its platform is also designed to entice users to return regularly and to encourage new users to subscribe to its website. In allowing merchant clients to study consumer behavior through data collected from a database of users’ activities, the company has focused on building a social customer relation management tool that allows business owners to engage in precision marketing.

The Moxian portfolio of products and services includes:

• Moxian+ App, an O2O business solution geared toward small and medium businesses that provides its users with a social media platform, which integrates entertainment, commerce, shopping and customer loyalty reward;
• A social marketing platform being designed and developed under the MO-Promo brand, which serves as an online sale promotion website for Moxian’s clients’ businesses; and
• MO-Reward, a reward giving back platform under development.

Moxian’s innovative platform and loyalty program is driving the company’s growth. In the summer of 2015, the company further solidified its market position when it entered into a subscription agreement with Beijing Xinhua Huifeng Equity Investment Centre, a limited partnership based in Beijing, China. To raise US$8.19 million. Moxian offered 8.19 million shares of its common stock to Xinhua Huifeng through a private placement. This sizable investment will allow Moxian to continue on the path its management has set for it and to continue to invest in its growth. It will also allow Xinhua Huifeng to help fund and contribute to Moxian’s future.

For more information, visit the company’s website at http://ir.moxian.com/html-en/

Let us hear your thoughts: Moxian, Inc. Message Board

Alzheimer’s and Autism are serious enough when the patient is confined to a controlled environment, but imagine when that person wanders off into the vast unknown with no caregiver to comfort and guide them safely home. This dreaded fear of losing a parent with Alzheimer’s or a child with Autism is very real for the families of more than 100 million people around the world today that require oversight due to some form of memory impairment. GTX Corp. (OTC: GTXO) is helping alleviate this fear with its GPS SmartSole technology.

The company’s tracking technology allows for the real-time monitoring of a loved one’s location with a simple shoe insole insert. The battery life is 2-3 days on a single charge, and the device show’s exactly where the wearer is located using a combination of satellite and cellular technology. Imagine the peace of mind associated with being able to keep track of your mom, dad, daughter or son through an app right on your smartphone.

Another significant feature of this technology is its ability to send notifications when the wearer leaves a predefined area. Just program the settings for the area around your house, school, senior living, hospital, etc., and enjoy a little more tranquility while your loved one gets the assistance they need. Operator assistance is also available 24/7 with SmartSoles.

Advances in technology like this are getting noticed around the globe, as this oversight problem is only getting worse. By 2050, the 100 million people mentioned earlier are expected to increase to 277 million, according to the 2013 World Alzheimer’s Report.

However, with every new problem comes a solution, or solutions. According to a recent US News and World Report article focusing on seven new technologies that will change the lives of seniors, SmartSoles, along with self-driving cars, nurse robots and smart homes, to name a few, will help mitigate some of the challenges associated with aging.

For more information, visit www.gtxcorp.com

Let us hear your thoughts: GTX Corp. Message Board

With Black Friday and Cyber Monday in the rear view mirror, there’s still enough time left in this year’s shopping season to head over the river and through the woods to the local mall for a few last minute gift items. For mom, dad and their growing family of four, however, this holiday shopping experience can include a level of anxiety to which only parents with young children can relate. Not only will their little ones have their senses bombarded with distracting sights, sounds and smells, their limited attention spans run counter to accomplishing the task at hand in any orderly and timely fashion.

Giggles N’ Hugs (OTC: GIGL) opened its first location over five years ago with a keen idea to curb some of the ‘what-to-do-with-kids’ dilemma when mall shopping beckons. Its concept to this day is truly unique, practical and healthy for the whole family. Promoting a healthy menu and surroundings aimed to captivate and meet the needs of children, the company’s plan is on track toward capturing a very lucrative niche for its shareholders. As of today, GIGL owns and operates three locations in greater Los Angeles, and has recently signed an agreement with a well-known New York investment bank to help expand its presence in the market.

The company’s healthy menu is gaining recognition and accolades among its customer base. High-quality organic food within a kid-friendly, casual dining area for adults featuring a huge play area is the model Giggles N’ Hugs has been successfully pursuing. Parents can relax while their children dine on the type of food their growing bodies need while enjoying play areas with birthday themes such as Superhero, Princess, Pirate and Mermaid, Jungle, Dinosaur and many others. Great reviews continue to roll in from customers and mall operators at each of its L.A. locations.

Giggles N Hugs, Inc. owns and operates kid-friendly restaurants with play areas for children 10 years old and younger in California. The company owns and operates a restaurant in the Westfield Mall in Century City, a restaurant in the Westfield Topanga shopping center in Woodland Hills, and a restaurant in the Glendale Galleria in Glendale, California. Founded in 2010, Giggles N Hugs, Inc. is based in Los Angeles, California.

For more information, please visit www.gigglesnhugs.com

Let us hear your thoughts: Giggles ‘N Hugs, Inc. Message Board

The global wearable technology market, worth only $750 million back in 2012, has maintained its show stopping growth pattern this year, spurred on by the planet’s biggest tech companies continuing to vie for the pole position in an ongoing race to become the dominant developer of what is seen as essentially the next mobile phone market. Transparency Market Research recently projected a forward CAGR of over 40 percent through 2018 for the space and leading tech-focused market research, analysis and advisory firm, International Data Corporation, estimates that more than 72 million units will ship by this year’s close, a whopping 173 percent jump over last year’s figure, and this figure is seen by IDC as growing to over 155 million units by 2019, on a CAGR of 42.6 percent.

One of the companies pushing the hardest is Intel (NASDAQ: INTC), which bought up Canadian high-tech sports eyewear maker Recon earlier this year. Intel even announced at its recent developer’s forum that the latest iteration of its America’s Greatest Makers contest will have its own long format reality TV show starting early next year.

The world’s biggest chip maker pumping the public for ideas clearly shows how aggressive the wearables game has become and even NASA is now leaning on the public in this way, running a contest to develop a smartwatch app for astronauts on the ISS using the Samsung (OTC: SSNLF) Gear 2 as a reference device for designs. This after units of Microsoft’s (NASDAQ: MSFT) augmented reality headset, HoloLens, never made it to the ISS, as they were lost earlier this year during the failed CRS-7 Falcon 9 resupply mission by Tesla (NASDAQ: TSLA) founder Elon Musk’s SpaceX.

According to emerging technology-focused independent market research and business intelligence firm IDTechEx, one of the big trends in wearables is the continuing efflorescence of advanced informatics as wearable electronics. This trend will naturally expand the footprint of wearables in the healthcare market considerably, with truly disruptive implementations in areas such as e-textiles promising billion dollar sales potential, especially for devices that capture the right mix of data capture, communication, and overall functionality. We are already seeing some of the first truly compelling fruits of this race, with companies like Philips (NYSE: PHG) Healthcare teaming up with Google (NASDAQ: GOOG; GOOGL) to merge Philips IntelliVue Solutions technologies with Google Glass, transferring real-time data directly to the eyepiece so that doctors can have a persistent HUD (heads-up display) feeding them patient vital signs, all without ever having to take their eyes off the procedure.

Philips, which developed the IntelliVue MX40 wearable patient monitor that can display real-time patient vital signs on its color touchscreen and yet is light and small enough for ambulatory patients to comfortably wear, has also teamed up with Accenture (NYSE: ACN) in order to fuse together big data and wearable tech in a solution targeted primarily at ALS patients. The proof of concept solution from Philips and Accenture ties together a wearable display with the Emotiv Insight Brainware, a 5-channel wireless headset that records brainwaves, resulting in a device that could provide a great deal of independence to ALS sufferers, as well as others with neurodegenerative diseases. There is a great deal of potential for real-time patient monitoring devices like this and the success of systems like the LifeWatch, a mobile phone connected remote cardiac monitoring wearable from the subsidiary of Switzerland-based telemedicine products and services provider LifeWatch AG (OTC: LFWWF), is a good indicator of how mobile-enabled healthcare wearables that can be used to safeguard lives will fare in coming years.

A new report out from Global Industry Analysts published by Research and Markets, indicates just how attractive the wearable medical device segment of the market is, with a 2020 projection of some $4.5 billion. One of the smaller and much more investor-accessible companies at the forefront of this segment is GTX Corp. (OTC: GTXO), developer of the patented GPS SmartSole®, which sits invisibly inside a piece of footwear and allows for real-time tracking of patients who have a tendency to wander, such as those with Alzheimer’s, dementia, autism, and TBI. Recently showcased in Munich at the Telefonica Digital Innovation Day 2015 and featured in AARP’s 2015 technology gear guide, the SmartSole even beat out Samsung’s Gear S at the 2015 CTIA “Hot for the Holidays” Super Mobility Awards in the Wearables, Health, Fitness and Wellness category, coming in second only to Microsoft’s smartwatch with heart rate monitor, the Microsoft Band.

Applications for the SmartSole however run far and wide beyond just healthcare. The device is quickly gaining ground in a variety of tracking roles, such as real-time monitoring of high value assets like foreign diplomats and other government employees, as well as high level executives. Former NFL pro Jack Brewer, who got his start with the Minnesota Vikings and was known as one of the top defensive backs and special teams players in the league, playing key leadership roles for the New York Giants and the Philadelphia Eagles before going on to found and be the CEO of The Brewer Group Companies, has even officially endorsed the SmartSole in this capacity. Brewer, whose career and charitable work constantly takes him all over the globe, uses the SmartSole as a way for family and colleagues to easily track his whereabouts, as well as view a detailed real-time trail of where he has been using the GTX Smart Locator app.

The SmartSole is an ingenious design, powerful enough to satisfy all the demands that consumers place upon such a solution, yet surreptitious enough to avoid the stigma cognitive impairment sufferers may experience, as well as detection by would-be kidnappers.

For more information, visit www.gtxcorp.com

Let us hear your thoughts: GTX Corp. Message Board